{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:09Z","timestamp":1786987689653,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.diabres.2021.108845","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:55:18Z","timestamp":1619740518000},"page":"108845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records database"],"prefix":"10.1016","volume":"178","author":[{"given":"Mitsuru","family":"Ohsugi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Eiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Iglay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Tetsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tokita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohjiro","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108845_b0005","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 9th Edition 2019. Available at: https:\/\/www.diabetesatlas.org\/en\/resources\/. Accessed March 24, 2021."},{"key":"10.1016\/j.diabres.2021.108845_b0010","unstructured":"Ministry of Health, Labor and Welfare. The National Health and Nutrition Survey (NHNS) Japan, 2016. Available at: https:\/\/www.nibiohn.go.jp\/eiken\/kenkounippon21\/download_files\/eiyouchousa\/2016.pdf. Accessed March 24, 2021."},{"key":"10.1016\/j.diabres.2021.108845_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/dc16-2736","article-title":"Cardiovascular disease and type 2 diabetes: Has the dawn of a new era arrived?","volume":"40","author":"Abdul-Ghani","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108845_b0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus","volume":"32","author":"Iglay","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2021.108845_b0025","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s13300-019-00698-9","article-title":"Prevalence of established cardiovascular disease in patients with type 2 diabetes mellitus in the UK","volume":"10","author":"Lautsch","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2021.108845_b0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2021.108845_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13340-015-0223-1","article-title":"A large-scale, observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 2 diabetes\u2014JDCP study 1","volume":"6","author":"Tajima","year":"2015","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2021.108845_b0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ije\/dyt057","article-title":"Cohort profile: The Japan Diabetes Complications study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes","volume":"43","author":"Tanaka","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.diabres.2021.108845_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1475-2840-12-164","article-title":"Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study","volume":"12","author":"Ikeda","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2021.108845_b0050","unstructured":"Japan Diabetes Society Treatment Guide for Diabetes 2016\u20132017. Available at: http:\/\/www.fa.kyorin.co.jp\/jds\/uploads\/Treatment_Guide_for_Diabetes_2016-2017.pdf. In English. Accessed March 24, 2021."},{"key":"10.1016\/j.diabres.2021.108845_b0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jdi.12550","article-title":"Duration of diabetes and types of diabetes therapy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention prospective study 3 (JDCP study 3)","volume":"8","author":"Hayashino","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2021.108845_b0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s13340-017-0326-y","article-title":"Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS)","volume":"8","author":"Sugiyama","year":"2017","journal-title":"Diabetol Int"},{"key":"10.1016\/j.diabres.2021.108845_b0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2021.108845_b0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/dom.13612","article-title":"How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study","volume":"21","author":"Birkeland","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2021.108845_b0075","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.113.002424","article-title":"Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961\u20132009)","volume":"128","author":"Hata","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108845_b0080","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2021.108845_b0085","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.je.2016.12.013","article-title":"Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan","volume":"27","author":"Yokomichi","year":"2017","journal-title":"J Epidemiol"},{"key":"10.1016\/j.diabres.2021.108845_b0090","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108845_b0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108845_b0100","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108845_b0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13300-019-00747-3","article-title":"Renal outcomes in type 2 diabetes: a review of cardiovascular and renal outcome trials","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2021.108845_b0110","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108845_b0115","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"Wheeler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2021.108845_b0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc19-2049","article-title":"The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54)","volume":"43","author":"Yokoyama","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108845_b0125","unstructured":"Ministry of Health, Labor and Welfare. [Summary of the National Health and Nutrition Survey, 2019]. Available at: https:\/\/www.mhlw.go.jp\/content\/10900000\/000687163.pdf. In Japanese. Accessed March 24, 2021."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:21:09Z","timestamp":1759173669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":25,"alternative-id":["S0168822721002047"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108845","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records database","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Merck Sharp & Dohme Corp. and The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108845"}}